Transgenic technology and the study of hepatitis viruses: a review of what we have learned.
about
DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?Generation of the regulatory protein rtTA transgenic mice.Tetracycline-inducible expression systems: new strategies and practices in the transgenic mouse modeling.Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice.Transgenic mice replicating hepatitis B virus but lacking expression of the major HBsAg.
P2860
Transgenic technology and the study of hepatitis viruses: a review of what we have learned.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Transgenic technology and the ...... eview of what we have learned.
@ast
Transgenic technology and the ...... eview of what we have learned.
@en
Transgenic technology and the ...... eview of what we have learned.
@nl
type
label
Transgenic technology and the ...... eview of what we have learned.
@ast
Transgenic technology and the ...... eview of what we have learned.
@en
Transgenic technology and the ...... eview of what we have learned.
@nl
prefLabel
Transgenic technology and the ...... eview of what we have learned.
@ast
Transgenic technology and the ...... eview of what we have learned.
@en
Transgenic technology and the ...... eview of what we have learned.
@nl
P356
P1476
Transgenic technology and the ...... eview of what we have learned.
@en
P2093
D R Milich
P304
P356
10.1155/2000/934202
P407
P577
2000-10-01T00:00:00Z